IST:SURGY Income Statement

Financials in millions TRY. Fiscal year is January - December.

Millions TRY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Administrative	187.86	198.85	126.94	91.98
Other Operating Expenses	0.94	3.04	1.85	-8.46
Total Operating Expenses	188.8	201.9	128.78	83.53
Operating Income	-188.8	-201.9	-128.78	-83.53
Interest Expense	-24.99	-1.09	-	-
Interest & Investment Income	-26.23	114.12	-	-
Currency Exchange Gain (Loss)	3.74	0.36	-2.3	-0.15
Other Non-Operating Income	-210.04	-204.72	-47.55	-51.63
EBT Excluding Unusual Items	-446.32	-293.23	-178.63	-135.31
Gain (Loss) on Sale of Investments	5.02	175.76	12.76	-
Asset Writedown	1,241	909.18	1,478	747.19
Pretax Income	799.2	791.71	1,313	611.88
Income Tax Expense	-796.15	462.95	-	-
Net Income	1,595	328.76	1,313	611.88
Net Income to Common	1,595	328.76	1,313	611.88
Net Income Growth	153.50%	-74.95%	114.51%	-
Basic Shares Outstanding	168	168	168	70
Diluted Shares Outstanding	168	168	168	70
Shares Change (YoY)	-9.15%	-	139.29%	-
EPS (Basic)	9.52	1.96	7.84	8.74
EPS (Diluted)	9.52	1.96	7.84	8.74
EPS Growth	179.04%	-74.95%	-10.36%	-
EBITDA	-187.13	-200.23	-128.13	-83.47
D&A For Ebitda	1.67	1.67	0.65	0.05
EBIT	-188.8	-201.9	-128.78	-83.53
Effective Tax Rate	-	58.48%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.